Psilocybin (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Psilocybin" in Czech language version.

refsWebsite

Global rank Czech rank

7nih.gov

4^th place

8^th place

3doi.org

2^nd place

4^th place

2web.archive.org

1^st place

1archive.org

6^th place

10^th place

1clinicaltrials.gov

5,225^th place

2,661^st place

1psychedelics.com

low place

1bpru.org

low place

archive.org (Global: 6^th place; Czech: 10^th place)

Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006, roč. 67, čís. 11, s. 1735–40. Dostupné online. PMID 17196053.

bpru.org (Global: low place; Czech: low place)

http://www.bpru.org/cancer/ Archivováno 7. 8. 2008 na Wayback Machine. recruitment notice for psilocybin clinical trial

clinicaltrials.gov (Global: 5,225^th place; Czech: 2,661^st place)

Psychopharmacology of Psilocybin in Cancer Patients - ClinicalTrials.gov

doi.org (Global: 2^nd place; Czech: 4^th place)

Passie T, Seifert J, Schneider U, Emrich HM. The pharmacology of psilocybin.. Addict Biol.. 2002, roč. 7, čís. 4, s. 357–64. doi:10.1080/1355621021000005937. PMID 14578010.
Wittmann M, Carter O, Hasler F, et al. Effects of psilocybin on time perception and temporal control of behaviour in humans. J. Psychopharmacol. (Oxford). January 2007, roč. 21, čís. 1, s. 50–64. Dostupné v archivu pořízeném dne 2020-07-16. doi:10.1177/0269881106065859. PMID 16714323.
Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Eur Psychiatry. 2005, roč. 20, čís. 5–6, s. 458–60. doi:10.1016/j.eurpsy.2005.04.008. PMID 15963699.

nih.gov (Global: 4^th place; Czech: 8^th place)

ncbi.nlm.nih.gov

Passie T, Seifert J, Schneider U, Emrich HM. The pharmacology of psilocybin.. Addict Biol.. 2002, roč. 7, čís. 4, s. 357–64. doi:10.1080/1355621021000005937. PMID 14578010.
Moreno FA, Wiegand CB, Taitano EK, Delgado PL. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. J Clin Psychiatry. 2006, roč. 67, čís. 11, s. 1735–40. Dostupné online. PMID 17196053.
Fischer R, England SM, Archer RC, Dean RK. Psilocybin reactivity and time contraction as measured by psychomotor performance. Arzneimittelforschung. February 1966, roč. 16, čís. 2, s. 180–5. PMID 6014013.
Wittmann M, Carter O, Hasler F, et al. Effects of psilocybin on time perception and temporal control of behaviour in humans. J. Psychopharmacol. (Oxford). January 2007, roč. 21, čís. 1, s. 50–64. Dostupné v archivu pořízeném dne 2020-07-16. doi:10.1177/0269881106065859. PMID 16714323.
Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. Hallucinogen persisting perception disorder after psilocybin consumption: a case study. Eur Psychiatry. 2005, roč. 20, čís. 5–6, s. 458–60. doi:10.1016/j.eurpsy.2005.04.008. PMID 15963699.

pubchem.ncbi.nlm.nih.gov

Psilocybine. pubchem.ncbi.nlm.nih.gov [online]. PubChem [cit. 2021-05-23]. Dostupné online. (anglicky)

chem.sis.nlm.nih.gov

NLM

psychedelics.com (Global: low place; Czech: low place)

http://psychedelics.com/psilocybe/psilocybin.html The Hallucinogenic Way of Dying

web.archive.org (Global: 1^st place; Czech: 1^st place)

http://www.bpru.org/cancer/ Archivováno 7. 8. 2008 na Wayback Machine. recruitment notice for psilocybin clinical trial
Wittmann M, Carter O, Hasler F, et al. Effects of psilocybin on time perception and temporal control of behaviour in humans. J. Psychopharmacol. (Oxford). January 2007, roč. 21, čís. 1, s. 50–64. Dostupné v archivu pořízeném dne 2020-07-16. doi:10.1177/0269881106065859. PMID 16714323.

Psilocybin (Czech Wikipedia)

archive.org (Global: 6th place; Czech: 10th place)